Ryman Healthcare Limited (ASX:RYM)
Australia · Delayed Price · Currency is AUD 2.520
0.00 (0.00%)
At close: Jan 9, 2026
Ryman Healthcare Market Cap
Ryman Healthcare has a market cap or net worth of 2.58 billion as of January 9, 2026. Its market cap has decreased by -5.64% in one year.
Market Cap
2.58B
Enterprise Value
4.03B
Revenue
707.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.52
Market Cap Chart
Since June 6, 2000, Ryman Healthcare's market cap has increased from 137.62M to 2.58B, an increase of 1,777.61%. That is a compound annual growth rate of 12.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 2.58B | 1.45% |
| Dec 31, 2025 | 2.55B | -12.90% |
| Dec 31, 2024 | 2.92B | -22.13% |
| Dec 29, 2023 | 3.76B | 49.41% |
| Dec 30, 2022 | 2.51B | -56.17% |
| Dec 31, 2021 | 5.73B | -18.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.11B |
| Pro Medicus | 22.56B |
| Cochlear | 17.27B |
| Sonic Healthcare | 11.04B |
| Ramsay Health Care | 8.20B |
| Ansell | 4.75B |
| Telix Pharmaceuticals | 3.84B |
| Mesoblast | 3.78B |